Arvinas (ARVN) Interest Coverage Ratio (2017 - 2021)
Arvinas (ARVN) recorded quarterly Interest Coverage Ratio of 703.7 in Q4 2021, up 87.91% quarter-over-quarter from 5821.54 in Q3 2021, and up 7.89% on a YoY basis from 652.21 in Q4 2020.
Arvinas (ARVN) Interest Coverage Ratio (2017 - 2021) Analysis & Trends
Arvinas' Interest Coverage Ratio history runs 5 years deep, the most recent figure standing at 703.7 for Q4 2021.
- In Q4 2021, Interest Coverage Ratio rose 7.89% year-over-year to 703.7; the TTM figure through Sep 2022 stood at 3485.93 (down 62.14% YoY), while the FY2021 annual figure was 1884.0, down 55.96% from the prior year.
- Interest Coverage Ratio was 703.7 for Q4 2021 at Arvinas, up from 5821.54 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 240.35 in Q3 2019 to a low of 6387.69 in Q2 2021.
- Historically, Interest Coverage Ratio has averaged 1448.65 across 5 years, with a median of 786.46 in 2019.
- The sharpest annual moves came in 2019 and 2020: Interest Coverage Ratio jumped 120.97% in 2019, then sank 912.86% in 2020.
- A 5-year view of Interest Coverage Ratio shows it stood at 463.45 in 2017, then tumbled by 48.4% to 687.76 in 2018, then plunged by 103.92% to 1402.46 in 2019, then surged by 45.52% to 764.02 in 2020, then advanced by 7.89% to 703.7 in 2021.
- The last three Interest Coverage Ratio figures came in at 703.7 (Q4 2021), 5821.54 (Q3 2021), and 6387.69 (Q2 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -703.70 |
| Sep 30, 2021 | -5,821.54 |
| Jun 30, 2021 | -6,387.69 |
| Mar 31, 2021 | -2,566.15 |
| Dec 31, 2020 | -764.02 |
| Sep 30, 2020 | -1,953.73 |
| Jun 30, 2020 | -1,629.78 |
| Mar 31, 2020 | -1,440.74 |
| Dec 31, 2019 | -1,402.46 |
| Sep 30, 2019 | 240.35 |
| Jun 30, 2019 | -808.89 |
| Mar 31, 2019 | -669.03 |
| Dec 31, 2018 | -687.76 |
| Sep 30, 2018 | -1,146.35 |
| Jun 30, 2018 | -862.89 |
| Mar 31, 2018 | -401.36 |
| Dec 31, 2017 | -463.45 |
| Sep 30, 2017 | -524.70 |
| Jun 30, 2017 | -518.36 |
| Mar 31, 2017 | -460.67 |